INDIA MARKET LENS
Companies◆ Mixed

Bharti Airtel, MCX, Laurus Labs look bullish on charts: Chandan Taparia

Motilal Oswal rate stocks including Bharti Airtel, Laurus Labs and Motilal Oswal.

· Business Standard Mkts

Stocks to buy: MCX has formed a bullish candle, reclaimed the 50-DEMA and started making higher highs, indicating renewed buying interest, explains Chandan Taparia of Motilal Oswal.

Where the names start from: Laurus Labs is at its 52-week high, +35.0% over three months; Bharti Airtel is 9% below its 52-week high, +0.9% over three months; Motilal Oswal is 13% below its 52-week high, +12.6% over three months. A rating is set against the price on the day the note is written, so how far a stock has already run is the part of the case the headline upside leaves out.

  • Brokerage calls from Motilal Oswal, with ratings on the stocks named. The stocks: Bharti Airtel, Laurus Labs and Motilal Oswal.
  • On the day, 2 of 3 are higher: Laurus Labs leads at +7.2% and Motilal Oswal trails at -4.5%.
  • Over three months: Bharti Airtel +0.9% against Telecom & Media +0.9% (0.0 points behind); Laurus Labs +35.0% against Pharma & Healthcare -0.9% (35.9 points ahead); Motilal Oswal +12.6% against Capital Markets -6.3% (18.9 points ahead).
  • Trading well above normal today: Laurus Labs at 4.2 times its 20-day average volume and Motilal Oswal at 2.4 times its 20-day average volume.
Figures for the companies in this story
CompanyPriceDay1M3MFrom 52-wk highVolume vs 20-dayMarket cap
Bharti AirtelBHARTIARTL · Telecom & Media₹1,973.70+0.1%+12.3%+0.9%-8.7%0.8×—
Laurus LabsLAURUSLABS · Pharma & Healthcare₹2,405.50+7.2%+21.5%+35.0%0.0%4.2×—
Motilal OswalMOTILALOFS · Capital Markets₹941.95-4.5%-5.2%+12.6%-12.9%2.4×—

Telecom & Media

1M -0.2% · 3M +0.9%

Bharti Airtel

Pharma & Healthcare

1M -0.6% · 3M -0.9%

Laurus Labs

Capital Markets

1M -2.9% · 3M -6.3%

Motilal Oswal

Prices as of 30 Oct 2026, 16:10 IST. Sector moves are the average of the stocks we track in each sector.

BHARTIARTLLAURUSLABSMOTILALOFSTelecom & MediaPharma & HealthcareCapital Markets